InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,980.48
(
-0.61%
)
US TECH 100
16,731.60
(
-1.21%
)
Dow Jones
37,995.71
(
0.58%
)
Brent Oil
86.78
(
0.42%
)
Bitcoin
64,413.75
(
1.42%
)
Post# of 10344
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Polyphemus

Send PM Follow Ignore
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Polyphemus

Re: blackngold63 post# 8621

Wednesday, 10/03/2018 4:31:55 PM

Wednesday, October 03, 2018 4:31:55 PM

Post# of 10344
I was making an important distinction between testing for sensitization as part of a biocompatibility program and a trial for effectiveness on real patients. Of course, informed consent is necessary to trial on humans, even purely safety studies.

Don't misrepresent the message.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!